Stocks and Investing Stocks and Investing
Mon, August 12, 2024

Serge Belanger Maintained (XENE) at Strong Buy with Decreased Target to $60 on, Aug 12th, 2024


Published on 2024-10-28 13:33:43 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy with Decreased Target from $62 to $60 on, Aug 12th, 2024.

Serge has made no other calls on XENE in the last 4 months.



There are 4 other peers that have a rating on XENE. Out of the 4 peers that are also analyzing XENE, 0 agree with Serge's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Serge


  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Friday, August 9th, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $49 on, Friday, August 9th, 2024
  • Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $55 on, Tuesday, June 18th, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $60 on, Friday, May 10th, 2024
Contributing Sources